Fusion Fund Research
Investment Thesis
Fusion Fund invests in early-stage startups that leverage technical or data advantages to build transformational businesses across healthcare, enterprise AI, and industrial technology. Founded in 2015 by Lu Zhang, a serial entrepreneur and Stanford Engineering alumna, the firm partners with technical founders who have deep domain expertise and the ability to commercialize cutting-edge innovations. Fusion Fund's thesis is rooted in the conviction that the best founders combine technical depth with operational excellence, and that access to an elite network of industry leaders significantly accelerates company growth.
Fund Profile
Fusion Fund IV, announced in March 2025, closed an oversubscribed $190 million fund in less than six months, bringing the firm's total assets under management to over $500 million. The fund's LP base includes endowments, foundations, sovereign wealth funds, large corporates, fund-of-funds, and strategic family offices. The institutional LP support and oversubscription rate underscore strong investor confidence in the team's track record and investment approach.
Investment Focus and Sectors
Fusion Fund focuses on three primary vertical markets:
Healthcare: AI-driven pathology, precision medicine, digital health, biotech, and medical devices leveraging data and technology advantages.
Enterprise AI: Next-generation AI infrastructure, enterprise software, data science platforms, and AI applications that improve business efficiency and decision-making. The firm is particularly focused on solutions that address rising demands for efficiency and scalability.
Industrial Technology: Industrial automation, robotics, logistics optimization, manufacturing innovation, and edge computing. The firm invests in companies building technical solutions for industrial applications.
Stage and Check Size
Fusion Fund invests across Pre-Seed, Seed, and Series A, with a geographic focus on the United States and Canada. Typical check sizes range from $500K to $5M, though the firm maintains reserves for follow-on investments. The fund favors being an early institutional investor and frequently leads or co-leads rounds with high-quality co-investors.
Recent Activity and Fund Status
Fusion Fund IV is actively deploying capital as of February 2026. Recent notable investments include:
- Somite AI (Series A, $47M led by Khosla Ventures, Q2 2025)
- Reality Defender (recognized as 2025 World Economic Forum Technology Pioneer)
- Blumind (Series A, $20M, Q1 2025)
- Rhino Federated Computing (Series A, $15M, 2024)
- Optimal Dynamics (Series B, $40M led by Koch Disruptive Technologies, 2025)
- Element Biosciences (Series D, $277M, 2024)
- Loft Labs (Series A, $24M led by Khosla Ventures, 2024)
Portfolio exits include Accern (acquired by Wand AI), Hollow Games (acquired by Take-Two 2024), and multiple IPOs and strategic acquisitions among portfolio companies.
Team and Operators
Fusion Fund is led by a team of technologists, operators, and former entrepreneurs:
Lu Zhang - Founder and Managing Partner with 20+ years in venture and startup experience. Serial entrepreneur with successful exits, investor with 4+ IPOs in her angel portfolio. Stanford Materials Science graduate with deep expertise in AI, healthcare, and deep tech commercialization.
David Gerster - Investment Partner with 15+ years in machine learning and data science at Yahoo, Microsoft, and Groupon. Leads enterprise AI investments.
Ivneet Bhullar - Investment Partner with advanced degrees in bioengineering and business, 10+ years in biotech research and innovation at Genentech and Amgen. Specializes in healthcare investments.
Shane Wall - Partner and President of the CXO Network, brings operational and executive leadership experience.
Ryan JB Taylor - Principal with investment and operational responsibilities.
The firm also includes venture partners, principals, and senior associates with strong technical and industry backgrounds. The team composition reflects Fusion Fund's core philosophy that venture investors should have deep technical expertise and entrepreneurial experience.
Competitive Advantages and Value Add
Beyond capital, Fusion Fund provides substantial operational support through two signature programs:
CXO Network: Comprised of 45+ Fortune 1000 and global corporate executives, this elite network connects portfolio companies to C-suite leaders for strategic guidance, market validation, and commercial partnerships. The network meets regularly to discuss AI implementation, cost-efficient infrastructure, enterprise security, and regulatory implications.
Fusion Expert Network: Includes 50+ industry technologists and leaders from Meta, Tesla, Google, and Amazon, providing specialized advisory support and deep technical expertise.
These ecosystem advantages enable early commercial traction and access to high-level talent that would typically be unavailable to early-stage startups.
Investment Process and Decision Making
Fusion Fund employs a thesis-driven, research-backed sourcing approach. The firm maintains a dynamic sourcing strategy leveraging:
- The annual Fusion VC Fellowship (4th cohort graduating in 2025) with top graduate-level talent in technical fields
- The exclusive Fusion Super Founder Network of serial entrepreneurs with successful exits
- Relationships with leading tech innovation centers
- Proprietary internal AI tools ("Ada") for deal sourcing, market analysis, and trend identification
Decision process involves partnership-level review, with investment committee discussions for significant check sizes. The team's technical backgrounds enable deep technical due diligence.
Geographic and Founder Preferences
Geographic focus is US and Canada, with particular strength in California, particularly the Bay Area. The firm invests in founders who:
- Have technical depth and specialized domain expertise
- Demonstrate entrepreneurial mindset and operational excellence
- Bring relevant experience from successful companies or deep industry background
- Are building defensible technology advantages through data or technical moats
Thought Leadership and Market Positioning
Fusion Fund has established itself as a thought leader in emerging technology trends. The firm published forward-looking industry reports on Edge Computing (2018), Network Security (2019), and AI in Healthcare (2020), well before these became mainstream sectors. Recent reports cover Digital Biology, AI Infrastructure, Space Tech, and FinTech.
The team, particularly Lu Zhang, is active in public speaking and appears regularly at major conferences discussing AI geopolitics, healthcare innovation, and emerging tech trends. This thought leadership helps the firm identify emerging opportunities and attract high-quality deal flow.
Notable Portfolio Successes
The portfolio spans 60+ companies with notable achievements:
- Multiple IPO exits (including You.com recognized as TIME Best Invention)
- Strategic acquisitions (Accern to Wand AI, Hollow Games to Take-Two)
- Series B/C/D companies with significant traction (Proscia $130M+ raised, Element Biosciences $277M Series D)
- Forbes/WEF recognition for portfolio companies (Reality Defender as 2025 Technology Pioneer)
- Portfolio company recognition on CNBC Disruptor 50 (GrubMarket 2024)
Fund Economics and Timeline
With $190M Fund IV and full deployment expected over 3-5 years, the fund is in early-to-mid deployment phase (approximately 12 months into the fund as of Q1 2026). Historical fund performance from Funds I-III provides evidence of successful exits and strong returns, leading to LP oversubscription for Fund IV.
Summary
Fusion Fund is an experienced early-stage venture capital firm with deep technical expertise, a proven track record of successful exits and portfolio company growth, and substantial operational support through its CXO and Expert Networks. The firm's focus on technical founders with data/technology advantages, combined with its ecosystem of Fortune 1000 executives and technical experts, provides unique value beyond capital. Fund IV's oversubscription and strong LP base indicate high institutional confidence in the team's ability to identify and scale transformational technology companies across healthcare, enterprise AI, and industrial technology.